Credits Available: 4.50 AMA PRA Category 1 Credit™ & 4.50 MOC points

Description: Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment landscape, while exciting, has created clinical challenges as health care providers struggle with translating these clinical trial results into real-world clinical practices in the adjuvant and neoadjuvant settings. This educational initiative establishes impactful small group interactions among oncology care providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with early-stage NSCLC.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Ludmila Svoboda

Dana-Farber Cancer Institute
Nurse Director Cancer Care Equity Program

Hi! My name is Ludmila and I am so excited to be here with all of you. I've worked in oncology for my entire career and have practiced in a great variety of settings from Manhattan to New Mexico, Haiti and Boston. My experience spans across solid tumor and liquid cancers and this breadth of experience has brought me to oncology education. I currently am the nurse director for the Cancer Care Equity Program at Dana-Farber Cancer Institute in Boston, a role that has allowed me to combine my love for oncology with my commitment to social justice and the elimination of disparities in access to cancer care for all, particularly historically marginalized groups.